Acasti Pharma(ACST) - 2023 Q1 - Earnings Call Transcript

Acasti Pharma Inc. (NASDAQ:ACST) Q1 2023 Earnings Conference Call August 11, 2022 1:00 PM ET Company Participants Robert Blum - Lytham Partners, Investor Relations Jan D'Alvise - President & Chief Executive Officer Brian Ford - Chief Financial Officer Pierre Lemieux - Chief Operating & Scientific Officer Prashant Kohli - Vice President, Commercial Operations Conference Call Participants Leland Gershell - Oppenheimer Operator Good day, and welcome to the Acasti Pharma's First Quarter Fiscal Year 2023 Financi ...